Erratum to: Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma

Philippe Moreau, Niels W C J van de Donk, Jesus San Miguel, Henk Lokhorst, Hareth Nahi, Dina Ben-Yehuda, Michele Cavo, Gordon Cook, Michel Delforge, Hermann Einsele, Sonja Zweegman, Heinz Ludwig, Christoph Driessen, Antonio Palumbo, Thierry Facon, Torben Plesner, Meletios Dimopoulos, Pia Sondergeld, Pieter Sonneveld, María-Victoria Mateos

Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

OriginalsprogEngelsk
TidsskriftDrugs
Vol/bind76
Udgave nummer9
Sider (fra-til)989-990
ISSN0012-6667
DOI
StatusUdgivet - jun. 2016

Citationsformater

Moreau, P., van de Donk, N. W. C. J., Miguel, J. S., Lokhorst, H., Nahi, H., Ben-Yehuda, D., Cavo, M., Cook, G., Delforge, M., Einsele, H., Zweegman, S., Ludwig, H., Driessen, C., Palumbo, A., Facon, T., Plesner, T., Dimopoulos, M., Sondergeld, P., Sonneveld, P., & Mateos, M-V. (2016). Erratum to: Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma. Drugs, 76(9), 989-990. https://doi.org/10.1007/s40265-016-0590-3